Global Respiratory Endotherapy Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

Description

List of Tables

Respiratory endotherapy devices are used to identify and treat respiratory problems such as tuberculosis, asthma, COPD, bronchitis, emphysema, interstitial lung diseases, lung tumours, pulmonary embolism, asthma, and many others. The most common forms of respiratory problems are cystic fibrosis and pulmonary asthma. Pulmonologists use the equipment to diagnose respiratory issues. Doctors use this equipment to perform the vast majority of bronchoscopy procedures. A tiny tube is inserted into the nose or mouth, through the throat, and lastly, into the lungs.

MARKET DYNAMICS:

The rising number of lung patients is expected to propel the market for respiratory endotherapy devices. Technological improvements have raised the need for respiratory endotherapy, which is expected to provide more profitable prospects in the respiratory endotherapy devices market. The rising awareness of pulmonary cancer screenings using CT scans is projected to enhance the need for accurate detection of tumours in the peripheral regions of the lungs by tissue biopsy, propelling the market for respiratory endotherapy devices. Many device manufacturers have spent in research & development activities to develop solutions for better respiratory diagnostics. Government laws concerning endoscopic problems are expected to influence the product's market growth negatively.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of respiratory endotherapy devices. The growth and trends of respiratory endotherapy devices industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the respiratory endotherapy devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Device Type

Diagnostic Devices
Biopsy Forceps
Cytology Brushes
Trans Bronchial Aspiration
Therapeutic Devices
Pulmonary Balloon Dilation Catheter
Airway Retrieved Basket
Tracheobronchial Stents
Pulmonary Stent System
Airway Stent
Bifurcated Trachea
Branchial Stent
Bronchial Thermoplasty
Bronchial Thermoplasty System

By End-User

Hospitals
Diagnostic Centers
Ambulatory Surgical Centers

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Respiratory Endotherapy Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the respiratory endotherapy devices market include Fujifilm Holdings Corporation, Medtronic, Johnson & Johnson, Smith & Nephew Plc., Stryker corporation, Olympus, Hoya corporation, Steris Healthcare, Conmed, Boston corporation, Vimex. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11219902

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . RESPIRATORY ENDOTHERAPY DEVICES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Device Type
- 3.7.2 Market Attractiveness Analysis By End-User
- 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL RESPIRATORY ENDOTHERAPY DEVICES MARKET ANALYSIS BY DEVICE TYPE

6.1 Overview by Device Type
6.2 Historical and Forecast Data
6.3 Analysis by Device Type
6.4 Diagnostic Devices Historic and Forecast Sales by Regions
6.5 Biopsy Forceps Historic and Forecast Sales by Regions
6.6 Cytology Brushes Historic and Forecast Sales by Regions
6.7 Trans Bronchial Aspiration Historic and Forecast Sales by Regions
6.8 Therapeutic Devices Historic and Forecast Sales by Regions
6.9 Pulmonary Balloon Dilation Catheter Historic and Forecast Sales by Regions
6.10. Airway Retrieved Basket Historic and Forecast Sales by Regions
6.11 Tracheobronchial Stents Historic and Forecast Sales by Regions
6.12 Pulmonary Stent System Historic and Forecast Sales by Regions
6.13 Airway Stent Historic and Forecast Sales by Regions
6.14 Bifurcated Trachea Historic and Forecast Sales by Regions
6.15 Branchial Stent Historic and Forecast Sales by Regions
6.16 Bronchial Thermoplasty Historic and Forecast Sales by Regions
6.17 Bronchial Thermoplasty System Historic and Forecast Sales by Regions

7 . GLOBAL RESPIRATORY ENDOTHERAPY DEVICES MARKET ANALYSIS BY END-USER

7.1 Overview by End-User
7.2 Historical and Forecast Data
7.3 Analysis by End-User
7.4 Hospitals Historic and Forecast Sales by Regions
7.5 Diagnostic Centers Historic and Forecast Sales by Regions
7.6 Ambulatory Surgical Centers Historic and Forecast Sales by Regions

8 . GLOBAL RESPIRATORY ENDOTHERAPY DEVICES MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE RESPIRATORY ENDOTHERAPY DEVICES COMPANIES

9.1. Respiratory Endotherapy Devices Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF RESPIRATORY ENDOTHERAPY DEVICES INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Fujifilm Holdings Corporation
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Medtronic
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Johnson & Johnson
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Smith & Nephew Plc.
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Stryker corporation
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Olympus
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Hoya corporation
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Steris Healthcare
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Conmed
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Boston corporation
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments
10.13. Vimex
- 10.13.1. Company Overview
- 10.13.2. Company Revenue
- 10.13.3. Products
- 10.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies